James K. McCloskey II, MD in Hackensack ...

Dr. James McCloskey

Claim this profile

Hackensack University Medical Center

Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Myeloid Leukemia
8 reported clinical trials
13 drugs studied

Area of expertise

1T-Lymphoblastic Leukemia/Lymphoma
James McCloskey has run 5 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
Philadelphia chromosome positive
BCR-ABL1 positive
Stage II
2Myeloid Leukemia
James McCloskey has run 4 trials for Myeloid Leukemia. Some of their research focus areas include:
Stage II
Stage I

Affiliated Hospitals

Image of trial facility.
Hackensack University Medical Center
Image of trial facility.
John Theurer Cancer Center At Hackensack University Medical Center

Clinical Trials James McCloskey is currently running

Image of trial facility.

CPX-351

for Acute Myeloid Leukemia

This is a phase IB/II study with a 3+3 dose de-escalation study design. Patients will continue maintenance treatment with CPX-351 for 6 cycles on D1 and D3, as long as patient remains in CR. The dose de-escalation will be one dose given on D1 only, every 28 days pending toxicity. The maximum tolerated dose will be used for the phase II expansion portion of the study.
Recruiting1 award Phase 1 & 2

More about James McCloskey

Clinical Trial Related9 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments James McCloskey has experience with
  • Placebo
  • Imatinib
  • Ponatinib
  • Azacitidine
  • MBG453
  • Vodobatinib (K0706)
Breakdown of trials James McCloskey has run
T-Lymphoblastic Leukemia/Lymphoma
Myeloid Leukemia
Acute Myeloid Leukemia
Myelofibrosis
Uterine Tumors

Other Doctors you might be interested in

David S SiegelHackensack University Medical Center
Mark Anderson, MDUniversity of Mississippi Medical Center
Lori Leslie, MDHackensack Meridian Health, John Theurer Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James McCloskey specialize in?
James McCloskey focuses on T-Lymphoblastic Leukemia/Lymphoma and Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved Philadelphia chromosome positive patients, or patients who are BCR-ABL1 positive.
Is James McCloskey currently recruiting for clinical trials?
Yes, James McCloskey is currently recruiting for 1 clinical trial in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that James McCloskey has studied deeply?
Yes, James McCloskey has studied treatments such as Placebo, Imatinib, Ponatinib.
What is the best way to schedule an appointment with James McCloskey?
Apply for one of the trials that James McCloskey is conducting.
What is the office address of James McCloskey?
The office of James McCloskey is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security